Monkeypox virus host factor screen using haploid cells identifies essential role of GARP complex in extracellular virus formation

Journal of Virology

Volumn 91, Issue 11, 2017, Pages

  Realegeno, Susan ^a   Puschnik, Andreas S ^b   Kumar, Amrita ^c   Goldsmith, Cynthia ^a   Burgado, Jillybeth ^a   Sambhara, Suryaprakash ^c   Olson, Victoria A ^a   Carroll, Darin ^a   Damon, Inger ^a   Hirata, Tetsuya ^d   Kinoshita, Taroh ^d   Carette, Jan E ^b   Satheshkumar, Panayampalli Subbian ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

GARP complex; HAP1 screen; Poxviruses; Retrograde transport

Indexed keywords

TECOVIRIMAT; ACTIN; BENZAMIDE DERIVATIVE; GLYCOSAMINOGLYCAN; GLYCOSYLPHOSPHATIDYLINOSITOL; ISOINDOLE DERIVATIVE; LRRC32 PROTEIN, HUMAN; MEMBRANE PROTEIN; ST-246; VESICULAR TRANSPORT PROTEIN; VPS53 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; ENDOSOME; GARP COMPLEX GENE; GENE; GENE FUNCTION; GENE IDENTIFICATION; GENETIC SCREENING; HAPLOIDY; HOST; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; MONKEYPOX; MONKEYPOX VIRUS; NONHUMAN; POXVIRUS INFECTION; PRIORITY JOURNAL; TRANS GOLGI NETWORK; VACUOLAR PROTEIN SORTING GENE; VIRION; VIROGENESIS; ANIMAL; BIOSYNTHESIS; CELL LINE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; GOLGI COMPLEX; HUMAN GENOME; METABOLISM; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL; VIROLOGY; VIRUS LOAD; VIRUS REPLICATION;

ACTINS; ANIMALS; BENZAMIDES; BIOLOGICAL TRANSPORT; CELL LINE; ENDOSOMES; GENOME, HUMAN; GLYCOSAMINOGLYCANS; GLYCOSYLPHOSPHATIDYLINOSITOLS; GOLGI APPARATUS; HAPLOIDY; HOST-PATHOGEN INTERACTIONS; HUMANS; ISOINDOLES; MEMBRANE PROTEINS; MONKEYPOX; MONKEYPOX VIRUS; MUTAGENESIS, INSERTIONAL; VESICULAR TRANSPORT PROTEINS; VIRAL LOAD; VIRUS REPLICATION;

EID: 85019235357     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00011-17     Document Type: Article

References (54)

1. Damon IK. 2013. Poxviruses, p 2160-2184. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 6th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Di Giulio DB, Eckburg PB. 2004. Human monkeypox: an emerging zoonosis. Lancet Infect Dis 4:15-25. https://doi.org/10.1016/S1473-3099 (03)00856-9.
3. Likos AM, Sammons SA, Olson VA, Frace AM, Li Y, Olsen-Rasmussen M, Davidson W, Galloway R, Khristova ML, Reynolds MG, Zhao H, Carroll DS, Curns A, Formenty P, Esposito JJ, Regnery RL, Damon IK. 2005. A tale of two clades: monkeypox viruses. J Gen Virol 86:2661-2672. https://doi .org/10.1099/vir.0.81215-0.
4. Saijo M, Ami Y, Suzaki Y, Nagata N, Iwata N, Hasegawa H, Iizuka I, Shiota T, Sakai K, Ogata M, Fukushi S, Mizutani T, Sata T, Kurata T, Kurane I, Morikawa S. 2009. Virulence and pathophysiology of the Congo Basin and West African strains of monkeypox virus in non-human primates. J Gen Virol 90:2266-2271. https://doi.org/10.1099/vir.0.010207-0.
5. Learned LA, Reynolds MG, Wassa DW, Li Y, Olson VA, Karem K, Stempora LL, Braden ZH, Kline R, Likos A, Libama F, Moudzeo H, Bolanda JD, Tarangonia P, Boumandoki P, Formenty P, Harvey JM, Damon IK. 2005. Extended interhuman transmission of monkeypox in a hospital community in the Republic of the Congo, 2003. Am J Trop Med Hyg 73: 428-434.
6. Reynolds MG, Damon IK. 2012. Outbreaks of human monkeypox after cessation of smallpox vaccination. Trends Microbiol 20:80-87. https://doi.org/10.1016/j.tim.2011.12.001.
7. Reed KD, Melski JW, Graham MB, Regnery RL, Sotir MJ, Wegner MV, Kazmierczak JJ, Stratman EJ, Li Y, Fairley JA, Swain GR, Olson VA, Sargent EK, Kehl SC, Frace MA, Kline R, Foldy SL, Davis JP, Damon IK. 2004. The detection of monkeypox in humans in the Western Hemisphere. N Engl J Med 350:342-350. https://doi.org/10.1056/NEJMoa032299.
8. Moss B. 2013. Poxviridae, p 2129-2159. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 6th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
9. Sanderson CM, Hollinshead M, Smith GL. 2000. The vaccinia virus A27L protein is needed for the microtubule-dependent transport of intracellular mature virus particles. J Gen Virol 81:47-58. https://doi.org/10.1099/0022-1317-81-1-47.
10. Ward BM. 2005. Visualization and characterization of the intracellular movement of vaccinia virus intracellular mature virions. J Virol 79: 4755-4763. https://doi.org/10.1128/JVI.79.8.4755-4763.2005.
11. Blasco R, Moss B. 1991. Extracellular vaccinia virus formation and cellto-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein. J Virol 65:5910-5920.
12. Blasco R, Moss B. 1992. Role of cell-associated enveloped vaccinia virus in cell-to-cell spread. J Virol 66:4170-4179.
13. Engelstad M, Smith GL. 1993. The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence. Virology 194:627-637. https://doi.org/10.1006/viro.1993.1302.
14. Payne LG. 1980. Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia. J Gen Virol 50:89-100. https://doi.org/10.1099/0022-1317-50-1-89.
15. Mercer J, Snijder B, Sacher R, Burkard C, Bleck CK, Stahlberg H, Pelkmans L, Helenius A. 2012. RNAi screening reveals proteasome-and Cullin3-dependent stages in vaccinia virus infection. Cell Rep 2:1036-1047. https://doi.org/10.1016/j.celrep.2012.09.003.
16. Sivan G, Martin SE, Myers TG, Buehler E, Szymczyk KH, Ormanoglu P, Moss B. 2013. Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. Proc Natl Acad Sci U S A 110:3519-3524. https://doi.org/10.1073/pnas.1300708110.
17. Filone CM, Caballero IS, Dower K, Mendillo ML, Cowley GS, Santagata S, Rozelle DK, Yen J, Rubins KH, Hacohen N, Root DE, Hensley LE, Connor J. 2014. The master regulator of the cellular stress response (HSF1) is critical for orthopoxvirus infection. PLoS Pathog 10:e1003904. https://doi.org/10.1371/journal.ppat.1003904.
18. Beard PM, Griffiths SJ, Gonzalez O, Haga IR, Pechenick Jowers T, Reynolds DK, Wildenhain J, Tekotte H, Auer M, Tyers M, Ghazal P, Zimmer R, Haas J. 2014. A loss of function analysis of host factors influencing vaccinia virus replication by RNA interference. PLoS One 9:e98431. https://doi.org/10.1371/journal.pone.0098431.
19. Moser TS, Sabin LR, Cherry S. 25 August 2010. RNAi screening for host factors involved in vaccinia virus infection using Drosophila cells. J Vis Exp https://doi.org/10.3791/2137.
20. Sivan G, Weisberg AS, Americo JL, Moss B. 12 September 2016. Retrograde transport from early endosomes to the trans-Golgi network enables membrane wrapping and egress of vaccinia virions. J Virol https://doi.org/10.1128/JVI.01114-16.
21. Harrison K, Haga IR, Pechenick Jowers T, Jasim S, Cintrat JC, Gillet D, Schmitt-John T, Digard P, Beard PM. 31 August 2016. Vaccinia virus uses retromer-independent cellular retrograde transport pathways to facilitate the wrapping of intracellular mature virions during viral morphogenesis. J Virol https://doi.org/10.1128/JVI.01464-16.
22. Carette JE, Raaben M, Wong AC, Herbert AS, Obernosterer G, Mulherkar N, Kuehne AI, Kranzusch PJ, Griffin AM, Ruthel G, Dal Cin P, Dye JM, Whelan SP, Chandran K, Brummelkamp TR. 2011. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 477: 340-343. https://doi.org/10.1038/nature10348.
23. Jae LT, Raaben M, Riemersma M, van Beusekom E, Blomen VA, Velds A, Kerkhoven RM, Carette JE, Topaloglu H, Meinecke P, Wessels MW, Lefeber DJ, Whelan SP, van Bokhoven H, Brummelkamp TR. 2013. Deciphering the glycosylome of dystroglycanopathies using haploid screens for lassa virus entry. Science 340:479-483. https://doi.org/10.1126/science.1233675.
24. Riblett AM, Blomen VA, Jae LT, Altamura LA, Doms RW, Brummelkamp TR, Wojcechowskyj JA. 2015. A haploid genetic screen identifies heparan sulfate proteoglycans supporting Rift Valley fever virus infection. J Virol 90:1414-1423. https://doi.org/10.1128/JVI.02055-15.
25. Pérez-Victoria FJ, Bonifacino JS. 2009. Dual roles of the mammalian GARP complex in tethering and SNARE complex assembly at the trans-Golgi network. Mol Cell Biol 29:5251-5263. https://doi.org/10.1128/MCB.00495-09.
26. Hirata T, Fujita M, Nakamura S, Gotoh K, Motooka D, Murakami Y, Maeda Y, Kinoshita T. 2015. Post-Golgi anterograde transport requires GARPdependent endosome-to-TGN retrograde transport. Mol Biol Cell 26: 3071-3084. https://doi.org/10.1091/mbc.E14-11-1568.
27. Duraffour S, Lorenzo MM, Zoller G, Topalis D, Grosenbach D, Hruby DE, Andrei G, Blasco R, Meyer H, Snoeck R. 2015. ST-246 is a key antiviral to inhibit the viral F13L phospholipase, one of the essential proteins for orthopoxvirus wrapping. J Antimicrob Chemother 70:1367-1380. https://doi.org/10.1093/jac/dku545.
28. Meiser A, Sancho C, Krijnse Locker J. 2003. Plasma membrane budding as an alternative release mechanism of the extracellular enveloped form of vaccinia virus from HeLa cells. J Virol 77:9931-9942. https://doi.org/10.1128/JVI.77.18.9931-9942.2003.
29. Tsutsui K. 1983. Release of vaccinia virus from FL cells infected with the IHD-W strain. J Electron Microsc (Tokyo) 32:125-140.
30. Stokes GV. 1976. High-voltage electron microscope study of the release of vaccinia virus from whole cells. J Virol 18:636-643.
31. Zhang WH, Wilcock D, Smith GL. 2000. Vaccinia virus F12L protein is required for actin tail formation, normal plaque size, and virulence. J Virol 74:11654-11662. https://doi.org/10.1128/JVI.74.24.11654-11662.2000.
32. Chou HT, Dukovski D, Chambers MG, Reinisch KM, Walz T. 2016. CATCHR, HOPS and CORVET tethering complexes share a similar architecture. Nat Struct Mol Biol 23:761-763. https://doi.org/10.1038/nsmb.3264.
33. Bonifacino JS, Hierro A. 2011. Transport according to GARP: receiving retrograde cargo at the trans-Golgi network. Trends Cell Biol 21: 159-167. https://doi.org/10.1016/j.tcb.2010.11.003.
34. Liewen H, Meinhold-Heerlein I, Oliveira V, Schwarzenbacher R, Luo G, Wadle A, Jung M, Pfreundschuh M, Stenner-Liewen F. 2005. Characterization of the human GARP (Golgi associated retrograde protein) complex. Exp Cell Res 306:24-34. https://doi.org/10.1016/j.yexcr.2005.01.022.
35. Vasile E, Oka T, Ericsson M, Nakamura N, Krieger M. 2006. IntraGolgi distribution of the Conserved Oligomeric Golgi (COG) complex. Exp Cell Res 312:3132-3141. https://doi.org/10.1016/j.yexcr.2006.06.005.
36. Pusapati GV, Luchetti G, Pfeffer SR. 2012. Ric1-Rgp1 complex is a guanine nucleotide exchange factor for the late Golgi Rab6A GTPase and an effector of the medial Golgi Rab33B GTPase. J Biol Chem 287: 42129-42137. https://doi.org/10.1074/jbc.M112.414565.
37. Jones KL, Schwarze U, Adam MP, Byers PH, Mefford HC. 2015. A homozygous B3GAT3 mutation causes a severe syndrome with multiple fractures, expanding the phenotype of linkeropathy syndromes. Am J Med Genet A 167A:2691-2696. https://doi.org/10.1002/ajmg.a.37209.
38. Nakajima M, Mizumoto S, Miyake N, Kogawa R, Iida A, Ito H, Kitoh H, Hirayama A, Mitsubuchi H, Miyazaki O, Kosaki R, Horikawa R, Lai A, Mendoza-Londono R, Dupuis L, Chitayat D, Howard A, Leal GF, Cavalcanti D, Tsurusaki Y, Saitsu H, Watanabe S, Lausch E, Unger S, Bonafe L, Ohashi H, Superti-Furga A, Matsumoto N, Sugahara K, Nishimura G, Ikegawa S. 2013. Mutations in B3GALT6, which encodes a glycosaminoglycan linker region enzyme, cause a spectrum of skeletal and connective tissue disorders. Am J Hum Genet 92:927-934. https://doi.org/10.1016/j.ajhg.2013.04.003.
39. Huang C, Zhou J, Wu S, Shan Y, Teng S, Yu L. 2004. Cloning and tissue distribution of the human B3GALT7 gene, a member of the beta1,3-glycosyltransferase family. Glycoconj J 21:267-273. https://doi.org/10.1023/B:GLYC.0000045098.78968.4c.
40. Carter GC, Law M, Hollinshead M, Smith GL. 2005. Entry of the vaccinia virus intracellular mature virion and its interactions with glycosaminoglycans. J Gen Virol 86:1279-1290. https://doi.org/10.1099/vir.0.80831-0.
41. Law M, Carter GC, Roberts KL, Hollinshead M, Smith GL. 2006. Ligandinduced and nonfusogenic dissolution of a viral membrane. Proc Natl Acad Sci U S A 103:5989-5994. https://doi.org/10.1073/pnas.0601025103.
42. Chiu WL, Lin CL, Yang MH, Tzou DL, Chang W. 2007. Vaccinia virus 4c (A26L) protein on intracellular mature virus binds to the extracellular cellular matrix laminin. J Virol 81:2149-2157. https://doi.org/10.1128/JVI.02302-06.
43. Sandgren KJ, Wilkinson J, Miranda-Saksena M, McInerney GM, Byth-Wilson K, Robinson PJ, Cunningham AL. 2010. A differential role for macropinocytosis in mediating entry of the two forms of vaccinia virus into dendritic cells. PLoS Pathog 6:e1000866. https://doi.org/10.1371/journal.ppat.1000866.
44. Schmidt FI, Bleck CK, Helenius A, Mercer J. 2011. Vaccinia extracellular virions enter cells by macropinocytosis and acid-activated membrane rupture. EMBO J 30:3647-3661. https://doi.org/10.1038/emboj.2011.245.
45. Kinoshita T. 2014. Biosynthesis and deficiencies of glycosylphosphatidylinositol. Proc Jpn Acad Ser B Phys Biol Sci 90:130-143. https://doi.org/10.2183/pjab.90.130.
46. Watanabe R, Murakami Y, Marmor MD, Inoue N, Maeda Y, Hino J, Kangawa K, Julius M, Kinoshita T. 2000. Initial enzyme for glycosylphosphatidylinositol biosynthesis requires PIG-P and is regulated by DPM2. EMBO J 19:4402-4411. https://doi.org/10.1093/emboj/19.16.4402.
47. Hong Y, Ohishi K, Kang JY, Tanaka S, Inoue N, Nishimura J, Maeda Y, Kinoshita T. 2003. Human PIG-U and yeast Cdc91p are the fifth subunit of GPI transamidase that attaches GPI-anchors to proteins. Mol Biol Cell 14:1780-1789. https://doi.org/10.1091/mbc.E02-12-0794.
48. Fujiwara I, Murakami Y, Niihori T, Kanno J, Hakoda A, Sakamoto O, Okamoto N, Funayama R, Nagashima T, Nakayama K, Kinoshita T, Kure S, Matsubara Y, Aoki Y. 2015. Mutations in PIGL in a patient with Mabry syndrome. Am J Med Genet A 167A:777-785. https://doi.org/10.1002/ajmg.a.36987.
49. Blomen VA, Majek P, Jae LT, Bigenzahn JW, Nieuwenhuis J, Staring J, Sacco R, van Diemen FR, Olk N, Stukalov A, Marceau C, Janssen H, Carette JE, Bennett KL, Colinge J, Superti-Furga G, Brummelkamp TR. 2015 Gene essentiality and synthetic lethality in haploid human cells. Science 350:1092-1096. https://doi.org/10.1126/science.aac7557.
50. Zaitseva M, Shotwell E, Scott J, Cruz S, King LR, Manischewitz J, Diaz CG, Jordan RA, Grosenbach DW, Golding H. 2013. Effects of postchallenge administration of ST-246 on dissemination of IHD-J-Luc vaccinia virus in normal mice and in immune-deficient mice reconstituted with T cells. J Virol 87:5564-5576. https://doi.org/10.1128/JVI.03426-12.
51. Huggins J, Goff A, Hensley L, Mucker E, Shamblin J, Wlazlowski C, Johnson W, Chapman J, Larsen T, Twenhafel N, Karem K, Damon IK, Byrd CM, Bolken TC, Jordan R, Hruby D. 2009. Nonhuman primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246. Antimicrob Agents Chemother 53:2620-2625. https://doi.org/10.1128/AAC.00021-09.
52. Lipovsky A, Popa A, Pimienta G, Wyler M, Bhan A, Kuruvilla L, Guie MA, Poffenberger AC, Nelson CD, Atwood WJ, DiMaio D. 2013. Genome-wide siRNA screen identifies the retromer as a cellular entry factor for human papillomavirus. Proc Natl Acad Sci U S A 110:7452-7457. https://doi.org/10.1073/pnas.1302164110.
53. Nelson CD, Carney DW, Derdowski A, Lipovsky A, Gee GV, O'Hara B, Williard P, DiMaio D, Sello JK, Atwood WJ. 2013. A retrograde trafficking inhibitor of ricin and Shiga-like toxins inhibits infection of cells by human and monkey polyomaviruses. mBio 4:e00729-13. https://doi.org/10.1128/mBio.00729-13.
54. Richmond JY, Nesby-O'Dell SL. 2002. Laboratory security and emergency response guidance for laboratories working with select agents. Centers for Disease Control and Prevention. MMWR Recomm Rep 51(RR-19):1-6.